<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Bariatric surgery: Postoperative and long-term management</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Bariatric surgery: Postoperative and long-term management</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Bariatric surgery: Postoperative and long-term management</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Giselle Hamad, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel Jones, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jun 23, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H18731256"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Obesity, a chronic illness identified in children, adolescents, and adults, has reached epidemic proportions worldwide [<a href="#rid1">1-4</a>]. In the United States alone, 42.5 percent of adults and 19.3 percent of children and adolescents were obese in 2017 to 2018 [<a href="#rid4">4-6</a>]. The rate of obesity has more than tripled since 1991 [<a href="#rid7">7,8</a>]. Worldwide, the rate of obesity has tripled between 1975 and 2016; more than 39 percent of adults and more than 18 percent of children in the world are obese or overweight [<a href="#rid9">9</a>].</p><p>Bariatric surgery, a commonly performed procedure in the United States [<a href="#rid10">10</a>], remains the most effective method of weight loss and can result in partial or complete resolution of multiple obesity-related comorbidities, including type 2 diabetes mellitus, hypertension, hypercholesterolemia, and obstructive sleep apnea [<a href="#rid11">11</a>]. </p><p>The immediate postoperative care for the postsurgical patient and outpatient management of all bariatric surgical patients will be discussed in this topic. The indications and types of bariatric procedures, complications, and outcomes are reviewed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/88536.html" rel="external">"Bariatric procedures for the management of severe obesity: Descriptions"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/87686.html" rel="external">"Bariatric operations: Early (fewer than 30 days) morbidity and mortality"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/140689.html" rel="external">"Bariatric operations: Late complications with acute presentations"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/90469.html" rel="external">"Outcomes of bariatric surgery"</a>.)</p><p></p><p class="headingAnchor" id="H18731262"><span class="h1">IN-HOSPITAL POSTOPERATIVE CARE</span><span class="headingEndMark"> — </span>Patients with an uncomplicated preoperative and intraoperative course are typically transferred from the operating room to the post-anesthesia unit and subsequently to the inpatient surgical floor. Continuous cardiac and oxygen saturation monitoring for 24 to 48 hours is recommended for patients with a history of cardiac arrhythmias or coronary artery disease and/or chronic obstructive pulmonary disease (COPD), sleep apnea, and/or asthma. (See <a class="local">'Regular inpatient unit'</a> below.)</p><p>Surgical intensive care unit (ICU) monitoring is rarely necessary following a bariatric operation unless the patient has complicated or refractory comorbid illnesses or the operation was complicated with a large amount of blood loss, cardiac instability, or the need for prolonged intubation. (See <a class="local">'Intensive care unit'</a> below.)</p><p class="headingAnchor" id="H27366697"><span class="h2">Post-anesthesia care unit</span><span class="headingEndMark"> — </span>Most stable patients undergoing a bariatric operation, including those patients without complicated preoperative comorbidities, are admitted to the post-anesthesia care unit (PACU) immediately at the conclusion of the operation. PACU management is reviewed separately. (See  <a class="medical medical_review" href="/d/html/14932.html" rel="external">"Anesthesia for the patient with obesity", section on 'Post-anesthesia care unit management'</a>.)</p><p class="headingAnchor" id="H817696714"><span class="h2">Intensive care unit</span><span class="headingEndMark"> — </span>Following a bariatric operation, most patients are managed in a standard inpatient postoperative surgical unit after a brief stay in the PACU; routine intensive care unit (ICU) admission is not necessary [<a href="#rid12">12</a>]. In an audit of over 12,000 patients undergoing bariatric surgery, ICU admission was required in only 4.9 percent, about one-third of which was unplanned [<a href="#rid13">13</a>]. Factors associated with ICU admission include older age, being male, and revisional surgery, while factors associated with unplanned ICU admission include revisional or open surgery, diabetes mellitus, chronic respiratory disease, and obstructive apnea. </p><p>For bariatric patients requiring an elective postoperative admission to the ICU, the median length of stay was one day, while the median length of stay was eight days for patients admitted to the ICU on an emergency basis [<a href="#rid14">14</a>]. </p><p class="headingAnchor" id="H18731268"><span class="h2">Regular inpatient unit</span><span class="headingEndMark"> — </span>After anesthetic and surgical management in the PACU is completed, most patients are transferred to the inpatient surgical postoperative unit. For the next 24 hours, the postoperative priorities include control of pain, nausea and/or vomiting, intravenous fluid management, pulmonary hygiene, and ambulation. Pain is controlled with oral <a class="drug drug_general" data-topicid="9729" href="/d/drug information/9729.html" rel="external">oxycodone</a>. Incentive spirometry is encouraged to reduce atelectasis. Oxygen is administered by nasal cannula in the PACU and weaned thereafter. Patients with obstructive sleep apnea are managed with continuous positive airway pressure (CPAP) [<a href="#rid15">15</a>].</p><p>Patients are allowed sips of water and ice chips on the night of surgery. Urine output is monitored overnight. Ambulation is encouraged beginning on the night of surgery. Antiemetics such as <a class="drug drug_general" data-topicid="9719" href="/d/drug information/9719.html" rel="external">ondansetron</a> are given as needed. </p><p>On postoperative day (POD) 1, a basic metabolic profile (eg, electrolytes, renal function blood tests) and a complete blood count are obtained. Patient’s diet is further advanced per institutional protocol. (See  <a class="medical medical_review" href="/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management", section on 'Early (postoperative) diet'</a>.)</p><p class="headingAnchor" id="H18731274"><span class="h2">Radiographic studies</span><span class="headingEndMark"> — </span>Routine use of upper gastrointestinal (UGI) series to rule out anastomotic or staple line leak has been shown to be low yield [<a href="#rid16">16,17</a>] and increases length of hospital stay [<a href="#rid18">18</a>]. Furthermore, there is evidence that the vast majority of staple line leaks after a sleeve gastrectomy (SG) are not diagnosed on routine postoperative UGI series; instead, they present clinically in 10 to 14 days after the patient has already been discharged [<a href="#rid19">19,20</a>].</p><p>Postoperative imaging studies and early complications following bariatric operations are reviewed elsewhere. (See  <a class="medical medical_review" href="/d/html/14953.html" rel="external">"Imaging studies after bariatric surgery"</a> and  <a class="medical medical_review" href="/d/html/87686.html" rel="external">"Bariatric operations: Early (fewer than 30 days) morbidity and mortality"</a>.) </p><p class="headingAnchor" id="H18731280"><span class="h2">Reoperation</span><span class="headingEndMark"> — </span>For patients who have an anastomotic leak or obstruction identified in the early postoperative period, an immediate return to the operating room for an exploration and revision is warranted. Such patients typically present with the following signs and symptoms (see  <a class="medical medical_review" href="/d/html/87686.html" rel="external">"Bariatric operations: Early (fewer than 30 days) morbidity and mortality"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Respiratory distress </strong>– Subtle indications of respiratory distress in the first few hours to days after bariatric surgery may reflect the respiratory compensation to lactic acidosis induced by substantial tissue hypoperfusion; this may be an early sign of an impending abdominal catastrophe.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sustained tachycardia</strong> – For patients who have undergone a Roux-en-Y gastric bypass (RYGB) or an SG and who develop sustained tachycardia of greater than 120 beats per minute without a cardiac event, an anastomotic leak or bleeding must be suspected [<a href="#rid21">21,22</a>]. There should be no delay in exploring these patients; a negative exploration is preferable to an undiagnosed leak and the potential for disastrous sequelae. One should not dismiss tachycardia; a leak may be present despite the absence of fever, leukocytosis, abdominal pain, or abdominal tenderness. (see  <a class="medical medical_review" href="/d/html/87686.html" rel="external">"Bariatric operations: Early (fewer than 30 days) morbidity and mortality", section on 'Gastrointestinal leak'</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Persistent vomiting </strong>–<strong> </strong>Persistent vomiting in the early postoperative period after RYGB is not routine. If there is bilious vomiting or dilated small bowel on radiographic studies (eg, abdominal films), a technical complication causing an obstruction is highly likely, and the patient should be re-explored promptly [<a href="#rid23">23,24</a>]. (See  <a class="medical medical_review" href="/d/html/87686.html" rel="external">"Bariatric operations: Early (fewer than 30 days) morbidity and mortality", section on 'Nausea, vomiting, and poor oral intake'</a>.)</p><p></p><p class="headingAnchor" id="H18731286"><span class="h2">Venous thromboembolism</span><span class="headingEndMark"> — </span>Most bariatric surgery patients are considered high risk for venous thromboembolism (VTE) given the prevalence of risk factors that promote VTE, including obesity, obstructive sleep apnea/hypoventilation syndrome, and exposure to general anesthesia. </p><p>Nevertheless, there is considerable variability among bariatric surgeons in the approach to thromboprophylaxis because of a lack of consensus regarding the optimal thromboprophylaxis strategy for this population [<a href="#rid25">25,26</a>]. The current American Society of Bariatric and Metabolic Surgeons (ASMBS) guidelines regarding VTE prophylaxis state that all bariatric patients receive mechanical prophylaxis and are recommended to ambulate early in the postoperative period. Additionally, the surgeon may routinely utilize chemical prophylaxis consisting of either low-molecular-weight heparin [<a href="#rid27">27</a>] or <a class="drug drug_general" data-topicid="8518" href="/d/drug information/8518.html" rel="external">unfractionated heparin</a> [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/d/html/584.html" rel="external">"Intensive care unit management of patients with obesity", section on 'Anticoagulants'</a>.)</p><p>Patients who are considered at a higher level of risk for VTE, such as patients with hypercoagulable disorders, history of previous VTE, or body mass index greater than 60 kg/m<sup>2</sup>, may be considered for extended administration of VTE prophylaxis [<a href="#rid29">29</a>]; there is no consensus regarding indications for extended prophylaxis for patients undergoing bariatric surgery [<a href="#rid30">30-32</a>].</p><p>Prevention of postoperative VTE is reviewed in detail separately. (See  <a class="medical medical_review" href="/d/html/1339.html" rel="external">"Prevention of venous thromboembolic disease in adult nonorthopedic surgical patients"</a>.)</p><p class="headingAnchor" id="H18731292"><span class="h2">Diabetes mellitus</span><span class="headingEndMark"> — </span>For patients with diabetes, serum glucose is monitored every six hours during the hospital admission with a goal of maintaining glucose levels between 140 and 180 mg/dL [<a href="#rid33">33</a>]. Close glucose monitoring is necessary after discharge, especially following RYGB, because of the risk of developing hypoglycemia after RYGB [<a href="#rid34">34</a>]. Preoperative classes are generally offered in bariatric centers to familiarize patients with a glucometer and insulin administration. Signs, symptoms, and treatment of hypoglycemia and hyperglycemia are discussed. The protocols for managing diabetes after bariatric surgery vary between centers. (See  <a class="medical medical_review" href="/d/html/1750.html" rel="external">"Overview of general medical care in nonpregnant adults with diabetes mellitus"</a> and  <a class="medical medical_review" href="/d/html/90469.html" rel="external">"Outcomes of bariatric surgery", section on 'Diabetes mellitus'</a>.)</p><p class="headingAnchor" id="H18731304"><span class="h1">POSTOPERATIVE CARE AFTER DISCHARGE</span><span class="headingEndMark"> — </span>Patients undergoing laparoscopic Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy (SG) are discharged on postoperative day 1 or 2, providing they are tolerating a clear liquid diet. The rare patients who have an open procedure remain hospitalized for a day or two longer or until they are able to tolerate a liquid diet and ambulate.</p><p class="headingAnchor" id="H190158069"><span class="h2">Hydration</span><span class="headingEndMark"> — </span>Patients must be educated preoperatively so that they know what to expect postoperatively, and this includes hydration. Fluid intake after discharge should be emphasized because of the vicious cycle of dehydration and nausea that often results in emergency room visits for dehydration.</p><p class="headingAnchor" id="H18731310"><span class="h2">Nutrition and supplementation</span><span class="headingEndMark"> — </span>Within the first 14 days after bariatric surgery, vitamin and mineral supplementation consists of a daily multivitamin for all patients [<a href="#rid35">35</a>]. Additional vitamin supplementation can be offered to RYGB and SG patients at the discretion of bariatric surgeons [<a href="#rid36">36,37</a>]. (See  <a class="medical medical_review" href="/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management", section on 'Micronutrient deficiency, supplementation, and repletion'</a>.)</p><p>In our practice, we recommend additional routine supplementation for RYGB patients with oral <a class="drug drug_general" data-topicid="9302" href="/d/drug information/9302.html" rel="external">vitamin B12</a> 500 micrograms daily, <a class="drug drug_general" data-topicid="9776" href="/d/drug information/9776.html" rel="external">vitamin C</a> 500 mg daily (taken with iron), <a class="drug drug_general" data-topicid="9185" href="/d/drug information/9185.html" rel="external">calcium carbonate</a> or citrate 500 mg twice a day, and <a class="drug drug_general" data-topicid="8444" href="/d/drug information/8444.html" rel="external">ferrous sulfate</a> 325 mg daily [<a href="#rid38">38-40</a>]. Calcium and iron supplementation should not be administered simultaneously. </p><p>SG patients should receive a multivitamin, <a class="drug drug_general" data-topicid="9302" href="/d/drug information/9302.html" rel="external">vitamin B12</a>, and iron supplementation [<a href="#rid41">41</a>]. Both RYGB and SG patients are at risk of vitamin D deficiency and require routine supplementation with <a class="drug drug_general" data-topicid="10117" href="/d/drug information/10117.html" rel="external">vitamin D3</a> 2000 international units daily [<a href="#rid42">42,43</a>].</p><p class="headingAnchor" id="H190158167"><span class="h3">Diet</span><span class="headingEndMark"> — </span>The dietary regimen depends upon the type of bariatric procedure performed. All patients are advised to avoid concentrated sweets and to avoid carbonation and straws when drinking liquids to minimize gastric bloating. (See  <a class="medical medical_review" href="/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management", section on 'Diet and texture progression'</a>.)</p><p>For patients undergoing an RYGB or SG procedure, they are instructed to limit oral intake to clear or full liquids for the first two weeks after discharge. They should consume 64 ounces (1.89 liters) of liquids daily since dehydration is a common reason for readmission. Patients are then advised to consume a pureed diet or full liquids for the next two weeks, then a soft diet for two months. At the third postoperative month, the patients are advanced to a regular diet. </p><p class="headingAnchor" id="H190158160"><span class="h3">Vitamin K</span><span class="headingEndMark"> — </span>For those patients requiring <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a>, close monitoring of prothrombin time and international normalized ratio (INR) is required when restarting warfarin postoperatively because of the tendency for these patients to become coagulopathic. This may be secondary to altered pharmacokinetics or pharmacodynamics, medication interactions, or an alteration in the absorption, intake, or storage of <a class="drug drug_general" data-topicid="9771" href="/d/drug information/9771.html" rel="external">vitamin K</a> [<a href="#rid44">44</a>]. Prothrombin time and INR should be obtained daily until the values stabilize.</p><p>The interaction of <a class="drug drug_general" data-topicid="9771" href="/d/drug information/9771.html" rel="external">vitamin K</a> and <a class="drug drug_general" data-topicid="10050" href="/d/drug information/10050.html" rel="external">warfarin</a> and the management of warfarin as an outpatient are reviewed separately:</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2624.html" rel="external">"Overview of vitamin K"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1334.html" rel="external">"Warfarin and other VKAs: Dosing and adverse effects"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1324.html" rel="external">"Management of warfarin-associated bleeding or supratherapeutic INR"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/1337.html" rel="external">"Biology of warfarin and modulators of INR control"</a>.)</p><p></p><p class="headingAnchor" id="H18731316"><span class="h2">Activity restrictions</span><span class="headingEndMark"> — </span>Patients must refrain from working for one to two weeks following a laparoscopic adjustable gastric banding operation and for two to four weeks following an RYGB and SG operation. Patients may shower but are instructed not to soak in a bathtub. They are also advised to avoid heavy housework and may not lift more than 10 pounds. </p><p class="headingAnchor" id="H18731322"><span class="h2">Medications</span><span class="headingEndMark"> — </span>Patients are sent home with <a class="drug drug_general" data-topicid="9729" href="/d/drug information/9729.html" rel="external">oxycodone</a> along with oral <a class="drug drug_general" data-topicid="9242" href="/d/drug information/9242.html" rel="external">acetaminophen</a> to reduce opiate utilization. Patients are advised not to drive a motor vehicle or operate heavy machinery while taking pain medication. </p><p>RYGB patients must not take <a class="drug drug_general" data-topicid="8547" href="/d/drug information/8547.html" rel="external">ibuprofen</a>, <a class="drug drug_general" data-topicid="9682" href="/d/drug information/9682.html" rel="external">naproxen</a>, or other anti-inflammatory medications because of the risk of gastrojejunal ulcer development [<a href="#rid45">45</a>]. They are not permitted to take <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a> unless they have a vascular or coronary stent or a prior cerebrovascular accident. Those who need to take aspirin or <a class="drug drug_general" data-topicid="9809" href="/d/drug information/9809.html" rel="external">prednisone</a> for medical conditions should also take a proton pump inhibitor to prevent marginal ulcers [<a href="#rid46">46</a>]. </p><p>In general, oral drug absorption decreases after bariatric surgery due to gastric restriction and/or intestinal bypass, among other anatomic and physiologic alterations [<a href="#rid47">47</a>]. Although there are no guidelines on how to address drug absorption after bariatric surgery, the following are considered good practices [<a href="#rid48">48</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Individualized medical counseling before hospital discharge.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Close monitoring by clinicians for adverse effect of drugs expected from change in absorption.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Frequent measurement of drug levels when tests are available.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>RYGB patients should crush tablets or take liquid medications. They may not crush extended-release medications or open capsules [<a href="#rid49">49</a>]. Because there is no anastomosis with an SG, there is no requirement to crush tablets or take liquid medications after SG.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If necessary, an intravenous or intramuscular route may be substituted for an oral route.</p><p></p><p>The exact change in absorption, however, is drug- and procedure-specific. Alterations in drug absorption after bariatric surgery that have been reported (mostly in case reports and pharmacokinetic studies) are summarized in this reference [<a href="#rid48">48</a>]. Information on dosing commonly prescribed drugs after bariatric surgery can be found in this reference [<a href="#rid50">50</a>]. Additionally, certain bariatric procedures may affect the absorption of direct oral anticoagulants  (<a class="graphic graphic_table graphicRef135133" href="/d/graphic/135133.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H18731328"><span class="h2">Warning signs of potential complications</span><span class="headingEndMark"> — </span>Patients should notify their surgeon for a temperature greater than 100.5°F (38.1°C), severe abdominal pain, redness around the incisions, drainage from the incisions, vomiting, chest pain, shortness of breath, or severe pain, warmth, or redness in the calf.</p><p class="headingAnchor" id="H18731334"><span class="h2">Follow-up schedule</span><span class="headingEndMark"> — </span>Follow-up schedules vary among bariatric surgeons. In the absence of postoperative complications, patients who had an RYGB or SG are typically scheduled for routine office visits at two and four weeks following discharge; then at 3, 6, and 12 months; then annually.</p><p class="headingAnchor" id="H18731340"><span class="h1">LONG-TERM MANAGEMENT</span><span class="headingEndMark"> — </span>Bariatric surgical patients require lifelong follow-up visits. Ongoing monitoring of body weight and compliance with the postsurgical regimen is necessary for long-term success and micronutrient deficiency detection [<a href="#rid38">38,51,52</a>]. </p><p>Long-term, all patients are encouraged to drink water and to avoid carbonation and straws, which promote gastric bloating. Caffeinated beverages should be avoided because of the diuretic effect [<a href="#rid53">53</a>]. Processed snack foods and sweetened beverages are discouraged because they carry little nutritional value and increase calorie intake. </p><p>Consumption of lean protein sources is encouraged. The need for vitamin and mineral supplementation should be reinforced at every visit to avoid micronutrient deficiencies [<a href="#rid54">54</a>]. Routine exercise should be encouraged [<a href="#rid55">55,56</a>]; walking is an appropriate way to start exercising. Patients with degenerative joint disease may benefit from aquatic exercise to reduce joint pain. </p><p class="headingAnchor" id="H18731346"><span class="h2">Multidisciplinary team</span><span class="headingEndMark"> — </span>Nurses and advanced practice providers assist the bariatric surgeon in addressing postoperative questions and concerns and can triage a patient who presents with a potential complication. A registered dietitian can optimize results by reinforcing the bariatric dietary regimen [<a href="#rid57">57</a>]. Free monthly support groups are offered and are attended by both preoperative and postoperative bariatric surgery patients. Our team also offers cooking classes, exercise classes, and behavioral therapy. (See  <a class="medical medical_review" href="/d/html/586.html" rel="external">"Bariatric surgery for management of obesity: Indications and preoperative preparation", section on 'Preoperative assessment'</a>.)</p><p class="headingAnchor" id="H18731352"><span class="h2">Assessment and management of changes in comorbid diseases</span><span class="headingEndMark"> — </span>Comorbidity status is routinely assessed at every postoperative visit, including hypertension, diabetes, metabolic deficiencies, hyperlipidemias, and sleep apnea. However, there is variability in the frequency and type of testing ordered among bariatric surgeons. Medication changes are typically managed by the primary care clinician or specialist (eg, cardiologist, endocrinologist). </p><p>Medical outcomes after a bariatric operation are reviewed elsewhere (see  <a class="medical medical_review" href="/d/html/90469.html" rel="external">"Outcomes of bariatric surgery", section on 'Metabolic effects'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypertension</strong> has been closely linked to obesity. Blood pressure is routinely measured at every postoperative visit to monitor response to the operation, and antihypertensive medications are reviewed. (See  <a class="medical medical_review" href="/d/html/3875.html" rel="external">"Overweight, obesity, and weight reduction in hypertension"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diabetes</strong> is effectively treated by bariatric surgery, and the need for insulin and/or oral hyperglycemics should be evaluated on each visit in the early postoperative time frame. HgA1C is followed to monitor diabetes severity, and changes in diabetic medications are reviewed. (See  <a class="medical medical_review" href="/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management"</a> and  <a class="medical medical_review" href="/d/html/1790.html" rel="external">"Management of persistent hyperglycemia in type 2 diabetes mellitus"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Metabolic deficiencies</strong> can be created by Roux-en-Y gastric bypass (RYGB) and are monitored by laboratory evaluations that include serum calcium, iron, <a class="drug drug_general" data-topicid="9302" href="/d/drug information/9302.html" rel="external">vitamin B12</a>, vitamin D, folate, and thiamine every six months for the first two years, then annually. (See  <a class="medical medical_review" href="/d/html/587.html" rel="external">"Bariatric surgery: Postoperative nutritional management", section on 'Micronutrient management'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyperlipidemia</strong> is monitored by evaluation of serum lipids and cholesterol and any medication adjusted accordingly. (See  <a class="medical medical_review" href="/d/html/112841.html" rel="external">"Management of low density lipoprotein cholesterol (LDL-C) in the secondary prevention of cardiovascular disease"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sleep apnea</strong> may be reassessed with a sleep study in 6 to 12 months after surgery to reassess the continuous positive airway pressure (CPAP) requirement. (See  <a class="medical medical_review" href="/d/html/7695.html" rel="external">"Obstructive sleep apnea: Overview of management in adults"</a> and  <a class="medical medical_review" href="/d/html/7706.html" rel="external">"Clinical presentation and diagnosis of obstructive sleep apnea in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastroesophageal reflux </strong>is common among SG patients [<a href="#rid58">58</a>]. (See  <a class="medical medical_review" href="/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults"</a> and  <a class="medical medical_review" href="/d/html/2263.html" rel="external">"Complications of gastroesophageal reflux in adults"</a> and  <a class="medical medical_review" href="/d/html/2278.html" rel="external">"Surgical treatment of gastroesophageal reflux in adults"</a>.)</p><p></p><p>Additional comorbid illnesses that may develop long-term (more than 30 days) following bariatric surgery are described in a separate topic and include (see  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations"</a>):</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dumping syndrome</strong> is assessed for patients who have undergone an RYGB procedure, which is particularly evident after patients consume sweet foods [<a href="#rid59">59</a>]. This may result in tachycardia, abdominal pain, diaphoresis, nausea, vomiting, diarrhea, and, later, hypoglycemia [<a href="#rid60">60</a>]. These patients should be counseled to take dietary measures to avoid the triggering food or drink. (See  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations", section on 'Dumping syndrome'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Marginal, or gastrojejunal, ulcers</strong> occur in up to 25 percent of RYGB patients and typically present with epigastric pain and nausea. Risk factors include tobacco, <a class="drug drug_general" data-topicid="8907" href="/d/drug information/8907.html" rel="external">aspirin</a>, and nonsteroidal anti-inflammatory medications (NSAIDs) [<a href="#rid45">45,61</a>]. Treatment consists of proton pump inhibitors, <a class="drug drug_general" data-topicid="9953" href="/d/drug information/9953.html" rel="external">sucralfate</a>, and discontinuation of the offending agents. If severe, marginal ulcers may be complicated by gastrointestinal (GI) bleeding or perforation. Prophylactic proton pump inhibitors have been advocated for ulcer prevention [<a href="#rid46">46,62</a>]. (See  <a class="medical medical_review" href="/d/html/140689.html" rel="external">"Bariatric operations: Late complications with acute presentations", section on 'Marginal ulcers'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cholelithiasis</strong> is a common cause of upper abdominal pain after bariatric surgery because of a change in bile composition [<a href="#rid63">63</a>]. In addition, rapid weight loss promotes gallstone formation [<a href="#rid64">64,65</a>]. Patients who still have their gallbladders are started on <a class="drug drug_general" data-topicid="10033" href="/d/drug information/10033.html" rel="external">ursodeoxycholic acid</a> (ursodiol) 300 mg orally twice a day for six months to prevent gallstone formation [<a href="#rid64">64</a>]. (See  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations", section on 'Cholelithiasis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Nephrolithiasis</strong> is prevalent among RYGB and SG patients [<a href="#rid66">66</a>]. RYGB patients are prone to an increase in oxaluria that can promote kidney stones and can progress to oxalate nephropathy and renal failure [<a href="#rid67">67,68</a>]. Therefore, patients should be counseled to avoid dietary oxalate. (See  <a class="medical medical_review" href="/d/html/585.html" rel="external">"Bariatric operations: Late complications with subacute presentations", section on 'Nephrolithiasis and renal failure'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Depression</strong> may be a preoperative comorbid illness or present as a postoperative manifestation. The bioavailability of serotonin reuptake inhibitor antidepressant medications is reduced after RYGB [<a href="#rid69">69</a>]; therefore, patients with mental illness may be at risk for exacerbation of depressive symptoms and should be monitored closely after RYGB. (See  <a class="medical medical_review" href="/d/html/90469.html" rel="external">"Outcomes of bariatric surgery", section on 'Depression'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stenosis</strong> following a sleeve gastrectomy (SG) can lead to gastric outlet obstruction and present as dysphagia or vomiting [<a href="#rid70">70</a>]. This is diagnosed by an upper gastrointestinal study and may be managed with endoscopic dilation. Surgical revision may be required if endoscopic management fails [<a href="#rid71">71</a>]. (See  <a class="medical medical_review" href="/d/html/140689.html" rel="external">"Bariatric operations: Late complications with acute presentations", section on 'Sleeve stenosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Unexplained abdominal pain</strong> can occur in any patient after an intra-abdominal operation. For patients who have had an RYGB procedure and present with unexplained abdominal pain, there should be a low threshold for offering surgical exploration, which may be approached laparoscopically, to identify an occult internal hernia, intussusception, or small bowel obstruction, even if physical examination is impressive and imaging studies are unrevealing. (See  <a class="medical medical_review" href="/d/html/14953.html" rel="external">"Imaging studies after bariatric surgery"</a> and  <a class="medical medical_review" href="/d/html/140689.html" rel="external">"Bariatric operations: Late complications with acute presentations", section on 'Small bowel obstruction'</a>.)</p><p></p><p class="headingAnchor" id="H18731364"><span class="h2">Improvements in physical function</span><span class="headingEndMark"> — </span>Bariatric surgery results in complete or partial resolution of multiple medical comorbidities as well as an improvement in quality of life [<a href="#rid72">72-74</a>]. Weight loss allows patients to increase their physical activity [<a href="#rid75">75</a>], which in turn promotes greater weight loss, cardiorespiratory fitness, and quality of life [<a href="#rid76">76</a>]. Exercise regimens are discussed, and patients are encouraged to incorporate both cardiovascular exercise and resistance training on a regular basis. Patients may elect to undergo body contouring surgery when their weight is stable to address hanging skin on the abdomen, buttocks, breasts, arms, and legs.</p><p class="headingAnchor" id="H363333993"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/112687.html" rel="external">"Society guideline links: Bariatric surgery"</a>.)</p><p class="headingAnchor" id="H18731370"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>In-hospital postoperative care</strong> – For the first 24 hours after the bariatric operation, the postoperative priorities include control of pain, nausea and/or vomiting, intravenous fluid management, pulmonary hygiene, and ambulation. (See <a class="local">'Regular inpatient unit'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Indications for reoperation in the early postoperative period</strong> – For patients who have an anastomotic leak, bleeding, or obstruction identified in the early postoperative period, an immediate return to the operating room for an exploration and revision is warranted. Sustained tachycardia over 120 beats per minute may be the presenting symptom of an intra-abdominal adverse event. (See <a class="local">'Reoperation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative care after discharge</strong> – Patient management after surgery includes an assessment of hydration and medical comorbid illnesses, such as hypertension, diabetes, and sleep apnea. (See <a class="local">'Postoperative care after discharge'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Long-term management</strong> – For long-term success and early identification of complications, lifelong follow-up is recommended after bariatric surgery. (See <a class="local">'Long-term management'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Friedrich MJ. Global Obesity Epidemic Worsening. JAMA 2017; 318:603.</a></li><li><a class="nounderline abstract_t">Alfaris N, Alqahtani AM, Alamuddin N, Rigas G. Global Impact of Obesity. Gastroenterol Clin North Am 2023; 52:277.</a></li><li><a class="nounderline abstract_t">Bray GA, Kim KK, Wilding JPH, World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Obes Rev 2017; 18:715.</a></li><li><a class="nounderline abstract_t">Hales CM, Fryar CD, Carroll MD, et al. Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016. JAMA 2018; 319:1723.</a></li><li><a class="nounderline abstract_t">NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. Lancet 2017; 390:2627.</a></li><li class="breakAll">Prevalence of overweight, obesity, and severe obesity among children and adolescents aged 2–19 years: United States, 1963–1965 Through 2017–2018. National Center for Health Statistics. Available at: https://www.cdc.gov/nchs/data/hestat/obesity-child-17-18/overweight-obesity-child-H.pdf (Accessed on May 20, 2023).</li><li><a class="nounderline abstract_t">QuickStats: Prevalence of Obesity* and Severe Obesity† Among Persons Aged 2-19 Years - National Health and Nutrition Examination Survey, 1999-2000 through 2017-2018. MMWR Morb Mortal Wkly Rep 2020; 69:390.</a></li><li><a class="nounderline abstract_t">Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991-1998. JAMA 1999; 282:1519.</a></li><li class="breakAll">Obesity and overweight. World Health Organization. Available at: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight (Accessed on May 20, 2023).</li><li><a class="nounderline abstract_t">Wolfe BM, Kvach E, Eckel RH. Treatment of Obesity: Weight Loss and Bariatric Surgery. Circ Res 2016; 118:1844.</a></li><li><a class="nounderline abstract_t">Nguyen NT, Varela JE. Bariatric surgery for obesity and metabolic disorders: state of the art. Nat Rev Gastroenterol Hepatol 2017; 14:160.</a></li><li><a class="nounderline abstract_t">Penna GLA, Vaz IP, Fonseca EC, et al. Immediate postoperative of bariatric surgery in the intensive care unit versus an inpatient unit. A retrospective study with 828 patients. Rev Bras Ter Intensiva 2017; 29:325.</a></li><li><a class="nounderline abstract_t">Morgan DJ, Ho KM, Armstrong J, Baker S. Incidence and risk factors for intensive care unit admission after bariatric surgery: a multicentre population-based cohort study. Br J Anaesth 2015; 115:873.</a></li><li><a class="nounderline abstract_t">van den Broek RJ, Buise MP, van Dielen FM, et al. Characteristics and outcome of patients admitted to the ICU following bariatric surgery. Obes Surg 2009; 19:560.</a></li><li><a class="nounderline abstract_t">de Raaff CAL, Gorter-Stam MAW, de Vries N, et al. Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline. Surg Obes Relat Dis 2017; 13:1095.</a></li><li><a class="nounderline abstract_t">Quartararo G, Facchiano E, Scaringi S, et al. Upper gastrointestinal series after Roux-en-Y gastric bypass for morbid obesity: effectiveness in leakage detection. a systematic review of the literature. Obes Surg 2014; 24:1096.</a></li><li><a class="nounderline abstract_t">Diaz Vico T, Elli EF. Utility of Immediate Postoperative Upper Gastrointestinal Contrast Study in Bariatric Surgery. Obes Surg 2019; 29:1130.</a></li><li><a class="nounderline abstract_t">Rahman U, Docimo S, Pryor AD, et al. Routine contrast imaging after bariatric surgery and the effect on hospital length of stay. Surg Obes Relat Dis 2018; 14:517.</a></li><li><a class="nounderline abstract_t">Sethi M, Magrath M, Somoza E, et al. The utility of radiological upper gastrointestinal series and clinical indicators in detecting leaks after laparoscopic sleeve gastrectomy: a case-controlled study. Surg Endosc 2016; 30:2266.</a></li><li><a class="nounderline abstract_t">Aurora AR, Khaitan L, Saber AA. Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients. Surg Endosc 2012; 26:1509.</a></li><li><a class="nounderline abstract_t">Arteaga-González I, Martín-Malagón A, Martín-Pérez J, Carrillo-Pallarés A. Usefulness of Clinical Signs and Diagnostic Tests for Suspected Leaks in Bariatric Surgery. Obes Surg 2015; 25:1680.</a></li><li><a class="nounderline abstract_t">Caputo V, Facchiano E, Soricelli E, et al. Small Bowel Obstruction After Laparoscopic Roux-en-Y Gastric Bypass Caused by Hemobezoar: A Case Series and Review of Literature. Surg Laparosc Endosc Percutan Tech 2021; 31:618.</a></li><li><a class="nounderline abstract_t">Khrucharoen U, Juo YY, Wongpongsalee T, et al. Risk factors for readmission for early small bowel obstruction following laparoscopic Roux-en-Y gastric bypass: an MBSAQIP analysis. Surg Obes Relat Dis 2021; 17:1041.</a></li><li><a class="nounderline abstract_t">Khoraki J, Mazzini GS, Shah AS, et al. Early small bowel obstruction after laparoscopic gastric bypass: a surgical emergency. Surg Obes Relat Dis 2018; 14:1118.</a></li><li><a class="nounderline abstract_t">Clark LN, Helm MC, Gould JC. Practice patterns regarding post-discharge chemoprophylaxis for venous thromboembolism following bariatric surgery in the United States. Surg Obes Relat Dis 2019; 15:703.</a></li><li><a class="nounderline abstract_t">Anderson DR, Morgano GP, Bennett C, et al. American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients. Blood Adv 2019; 3:3898.</a></li><li><a class="nounderline abstract_t">Birkmeyer NJ, Finks JF, Carlin AM, et al. Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery. Arch Surg 2012; 147:994.</a></li><li><a class="nounderline abstract_t">American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients. Surg Obes Relat Dis 2013; 9:493.</a></li><li><a class="nounderline abstract_t">Aminian A, Andalib A, Khorgami Z, et al. Who Should Get Extended Thromboprophylaxis After Bariatric Surgery?: A Risk Assessment Tool to Guide Indications for Post-discharge Pharmacoprophylaxis. Ann Surg 2017; 265:143.</a></li><li><a class="nounderline abstract_t">Hamad GG, Choban PS. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study. Obes Surg 2005; 15:1368.</a></li><li><a class="nounderline abstract_t">Raftopoulos I, Martindale C, Cronin A, Steinberg J. The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial. Surg Endosc 2008; 22:2384.</a></li><li><a class="nounderline abstract_t">Thereaux J, Lesuffleur T, Czernichow S, et al. To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients. Ann Surg 2018; 267:727.</a></li><li><a class="nounderline abstract_t">Mechanick JI, Apovian C, Brethauer S, et al. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures - 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring) 2020; 28:O1.</a></li><li><a class="nounderline abstract_t">Lee CJ, Brown TT, Schweitzer M, et al. The incidence and risk factors associated with developing symptoms of hypoglycemia after bariatric surgery. Surg Obes Relat Dis 2018; 14:797.</a></li><li><a class="nounderline abstract_t">Parrott J, Frank L, Rabena R, et al. American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients. Surg Obes Relat Dis 2017; 13:727.</a></li><li><a class="nounderline abstract_t">Johnson LM, Ikramuddin S, Leslie DB, et al. Analysis of vitamin levels and deficiencies in bariatric surgery patients: a single-institutional analysis. Surg Obes Relat Dis 2019; 15:1146.</a></li><li><a class="nounderline abstract_t">Antoniewicz A, Kalinowski P, Kotulecka KJ, et al. Nutritional Deficiencies in Patients after Roux-en-Y Gastric Bypass and Sleeve Gastrectomy during 12-Month Follow-Up. Obes Surg 2019; 29:3277.</a></li><li><a class="nounderline abstract_t">Levinson R, Silverman JB, Catella JG, et al. Pharmacotherapy prevention and management of nutritional deficiencies post Roux-en-Y gastric bypass. Obes Surg 2013; 23:992.</a></li><li><a class="nounderline abstract_t">Poitou Bernert C, Ciangura C, Coupaye M, et al. Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment. Diabetes Metab 2007; 33:13.</a></li><li><a class="nounderline abstract_t">Vargas-Ruiz AG, Hernández-Rivera G, Herrera MF. Prevalence of iron, folate, and vitamin B12 deficiency anemia after laparoscopic Roux-en-Y gastric bypass. Obes Surg 2008; 18:288.</a></li><li><a class="nounderline abstract_t">Jamil O, Gonzalez-Heredia R, Quadri P, et al. Micronutrient Deficiencies in Laparoscopic Sleeve Gastrectomy. Nutrients 2020; 12.</a></li><li><a class="nounderline abstract_t">Moore CE, Sherman V. Vitamin D supplementation efficacy: sleeve gastrectomy versus gastric bypass surgery. Obes Surg 2014; 24:2055.</a></li><li><a class="nounderline abstract_t">Vix M, Liu KH, Diana M, et al. Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial. Surg Endosc 2014; 28:821.</a></li><li><a class="nounderline abstract_t">Martin KA, Lee CR, Farrell TM, Moll S. Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance. Am J Med 2017; 130:517.</a></li><li><a class="nounderline abstract_t">Beran A, Shaear M, Al-Mudares S, et al. Predictors of marginal ulcer after gastric bypass: a systematic review and meta-analysis. J Gastrointest Surg 2023; 27:1066.</a></li><li><a class="nounderline abstract_t">Giannopoulos S, Athanasiadis DI, Clapp B, et al. Proton pump inhibitor prophylaxis after Roux-en-Y gastric bypass: A national survey of surgeon practices. Surg Obes Relat Dis 2023; 19:303.</a></li><li><a class="nounderline abstract_t">Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev 2010; 11:41.</a></li><li><a class="nounderline abstract_t">Alalwan AA, Friedman J, Alfayez O, Hartzema A. Drug absorption in bariatric surgery patients: A narrative review. Health Sci Rep 2022; 5:e605.</a></li><li><a class="nounderline abstract_t">Mitchell JF, Pawlicki KS. Oral solid dosage forms that should not be crushed: 1994 revision. Hosp Pharm 1994; 29:666.</a></li><li><a class="nounderline abstract_t">Kingma JS, Burgers DMT, Monpellier VM, et al. Oral drug dosing following bariatric surgery: General concepts and specific dosing advice. Br J Clin Pharmacol 2021; 87:4560.</a></li><li><a class="nounderline abstract_t">Colossi FG, Casagrande DS, Chatkin R, et al. Need for multivitamin use in the postoperative period of gastric bypass. Obes Surg 2008; 18:187.</a></li><li><a class="nounderline abstract_t">Kim HJ, Madan A, Fenton-Lee D. Does patient compliance with follow-up influence weight loss after gastric bypass surgery? A systematic review and meta-analysis. Obes Surg 2014; 24:647.</a></li><li><a class="nounderline abstract_t">Bird ET, Parker BD, Kim HS, Coffield KS. Caffeine ingestion and lower urinary tract symptoms in healthy volunteers. Neurourol Urodyn 2005; 24:611.</a></li><li><a class="nounderline abstract_t">Ziegler O, Sirveaux MA, Brunaud L, et al. Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies. Diabetes Metab 2009; 35:544.</a></li><li><a class="nounderline abstract_t">Chapman N, Hill K, Taylor S, et al. Patterns of physical activity and sedentary behavior after bariatric surgery: an observational study. Surg Obes Relat Dis 2014; 10:524.</a></li><li><a class="nounderline abstract_t">Hassannejad A, Khalaj A, Mansournia MA, et al. The Effect of Aerobic or Aerobic-Strength Exercise on Body Composition and Functional Capacity in Patients with BMI ≥35 after Bariatric Surgery: a Randomized Control Trial. Obes Surg 2017; 27:2792.</a></li><li><a class="nounderline abstract_t">Endevelt R, Ben-Assuli O, Klain E, Zelber-Sagi S. The role of dietician follow-up in the success of bariatric surgery. Surg Obes Relat Dis 2013; 9:963.</a></li><li><a class="nounderline abstract_t">Gu L, Chen B, Du N, et al. Relationship Between Bariatric Surgery and Gastroesophageal Reflux Disease: a Systematic Review and Meta-analysis. Obes Surg 2019; 29:4105.</a></li><li><a class="nounderline abstract_t">Emous M, Wolffenbuttel BHR, Totté E, van Beek AP. The short- to mid-term symptom prevalence of dumping syndrome after primary gastric-bypass surgery and its impact on health-related quality of life. Surg Obes Relat Dis 2017; 13:1489.</a></li><li><a class="nounderline abstract_t">Nielsen JB, Pedersen AM, Gribsholt SB, et al. Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass. Surg Obes Relat Dis 2016; 12:1562.</a></li><li><a class="nounderline abstract_t">Rodrigo DC, Jill S, Daniel M, et al. Which Factors Correlate with Marginal Ulcer After Surgery for Obesity? Obes Surg 2020; 30:4821.</a></li><li><a class="nounderline abstract_t">Chiappetta S, Stier C, Ghanem OM, et al. Perioperative Interventions to Prevent Gastroesophageal Reflux Disease and Marginal Ulcers After Bariatric Surgery - an International Experts' Survey. Obes Surg 2023; 33:1449.</a></li><li><a class="nounderline abstract_t">Browning MG, Pessoa BM, Khoraki J, Campos GM. Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery. Curr Obes Rep 2019; 8:175.</a></li><li><a class="nounderline abstract_t">Uy MC, Talingdan-Te MC, Espinosa WZ, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg 2008; 18:1532.</a></li><li><a class="nounderline abstract_t">Adams LB, Chang C, Pope J, et al. Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy. Obes Surg 2016; 26:990.</a></li><li><a class="nounderline abstract_t">Laurenius A, Sundbom M, Ottosson J, et al. Incidence of Kidney Stones After Metabolic and Bariatric Surgery-Data from the Scandinavian Obesity Surgery Registry. Obes Surg 2023; 33:1564.</a></li><li><a class="nounderline abstract_t">Duffey BG, Alanee S, Pedro RN, et al. Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study. J Am Coll Surg 2010; 211:8.</a></li><li><a class="nounderline abstract_t">Upala S, Jaruvongvanich V, Sanguankeo A. Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis. Surg Obes Relat Dis 2016; 12:1513.</a></li><li><a class="nounderline abstract_t">Hamad GG, Helsel JC, Perel JM, et al. The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors. Am J Psychiatry 2012; 169:256.</a></li><li><a class="nounderline abstract_t">Burgos AM, Csendes A, Braghetto I. Gastric stenosis after laparoscopic sleeve gastrectomy in morbidly obese patients. Obes Surg 2013; 23:1481.</a></li><li><a class="nounderline abstract_t">Deslauriers V, Beauchamp A, Garofalo F, et al. Endoscopic management of post-laparoscopic sleeve gastrectomy stenosis. Surg Endosc 2018; 32:601.</a></li><li><a class="nounderline abstract_t">Lindekilde N, Gladstone BP, Lübeck M, et al. The impact of bariatric surgery on quality of life: a systematic review and meta-analysis. Obes Rev 2015; 16:639.</a></li><li><a class="nounderline abstract_t">Monpellier VM, Antoniou EE, Aarts EO, et al. Improvement of Health-Related Quality of Life After Roux-en-Y Gastric Bypass Related to Weight Loss. Obes Surg 2017; 27:1168.</a></li><li><a class="nounderline abstract_t">Andersen JR, Aasprang A, Karlsen TI, et al. Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies. Surg Obes Relat Dis 2015; 11:466.</a></li><li><a class="nounderline abstract_t">King WC, Hsu JY, Belle SH, et al. Pre- to postoperative changes in physical activity: report from the longitudinal assessment of bariatric surgery-2 (LABS-2). Surg Obes Relat Dis 2012; 8:522.</a></li><li><a class="nounderline abstract_t">Nuijten MAH, Tettero OM, Wolf RJ, et al. Changes in Physical Activity in Relation to Body Composition, Fitness and Quality of Life after Primary Bariatric Surgery: a Two-Year Follow-Up Study. Obes Surg 2021; 31:1120.</a></li></ol></div><div id="topicVersionRevision">Topic 88610 Version 18.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28810033" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Global Obesity Epidemic Worsening.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37197873" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Global Impact of Obesity.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28489290" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29570750" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Trends in Obesity and Severe Obesity Prevalence in US Youth and Adults by Sex and Age, 2007-2008 to 2015-2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29029897" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29029897" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32240130" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : QuickStats: Prevalence of Obesity* and Severe Obesity†Among Persons Aged 2-19 Years - National Health and Nutrition Examination Survey, 1999-2000 through 2017-2018.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10546690" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : The spread of the obesity epidemic in the United States, 1991-1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10546690" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The spread of the obesity epidemic in the United States, 1991-1998.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27230645" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Treatment of Obesity: Weight Loss and Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27899816" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Bariatric surgery for obesity and metabolic disorders: state of the art.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29044303" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Immediate postoperative of bariatric surgery in the intensive care unit versus an inpatient unit. A retrospective study with 828 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26582848" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Incidence and risk factors for intensive care unit admission after bariatric surgery: a multicentre population-based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18830784" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Characteristics and outcome of patients admitted to the ICU following bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28666588" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24817427" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Upper gastrointestinal series after Roux-en-Y gastric bypass for morbid obesity: effectiveness in leakage detection. a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30542825" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Utility of Immediate Postoperative Upper Gastrointestinal Contrast Study in Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29428692" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Routine contrast imaging after bariatric surgery and the effect on hospital length of stay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26416376" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The utility of radiological upper gastrointestinal series and clinical indicators in detecting leaks after laparoscopic sleeve gastrectomy: a case-controlled study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22179470" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Sleeve gastrectomy and the risk of leak: a systematic analysis of 4,888 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25680577" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Usefulness of Clinical Signs and Diagnostic Tests for Suspected Leaks in Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34091483" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Small Bowel Obstruction After Laparoscopic Roux-en-Y Gastric Bypass Caused by Hemobezoar: A Case Series and Review of Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33965351" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Risk factors for readmission for early small bowel obstruction following laparoscopic Roux-en-Y gastric bypass: an MBSAQIP analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29945755" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Early small bowel obstruction after laparoscopic gastric bypass: a surgical emergency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31005460" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Practice patterns regarding post-discharge chemoprophylaxis for venous thromboembolism following bariatric surgery in the United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31794602" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23165612" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Comparative effectiveness of unfractionated and low-molecular-weight heparin for prevention of venous thromboembolism following bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23769113" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : ASMBS updated position statement on prophylactic measures to reduce the risk of venous thromboembolism in bariatric surgery patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28009739" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Who Should Get Extended Thromboprophylaxis After Bariatric Surgery?: A Risk Assessment Tool to Guide Indications for Post-discharge Pharmacoprophylaxis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16354513" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18622558" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28475558" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : To What Extent Does Posthospital Discharge Chemoprophylaxis Prevent Venous Thromboembolism After Bariatric Surgery?: Results From a Nationwide Cohort of More Than 110,000 Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32202076" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures - 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29678347" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : The incidence and risk factors associated with developing symptoms of hypoglycemia after bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28392254" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : American Society for Metabolic and Bariatric Surgery Integrated Health Nutritional Guidelines for the Surgical Weight Loss Patient 2016 Update: Micronutrients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31202681" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Analysis of vitamin levels and deficiencies in bariatric surgery patients: a single-institutional analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31201694" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Nutritional Deficiencies in Patients after Roux-en-Y Gastric Bypass and Sleeve Gastrectomy during 12-Month Follow-Up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23558789" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Pharmacotherapy prevention and management of nutritional deficiencies post Roux-en-Y gastric bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17258928" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Nutritional deficiency after gastric bypass: diagnosis, prevention and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18214631" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Prevalence of iron, folate, and vitamin B12 deficiency anemia after laparoscopic Roux-en-Y gastric bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32971950" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Micronutrient Deficiencies in Laparoscopic Sleeve Gastrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24748475" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Vitamin D supplementation efficacy: sleeve gastrectomy versus gastric bypass surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24196556" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Impact of Roux-en-Y gastric bypass versus sleeve gastrectomy on vitamin D metabolism: short-term results from a prospective randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28159600" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Oral Anticoagulant Use After Bariatric Surgery: A Literature Review and Clinical Guidance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36795250" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Predictors of marginal ulcer after gastric bypass: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36379840" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Proton pump inhibitor prophylaxis after Roux-en-Y gastric bypass: A national survey of surgeon practices.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19493300" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : A systematic review of drug absorption following bariatric surgery and its theoretical implications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35509385" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Drug absorption in bariatric surgery patients: A narrative review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10135147" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Oral solid dosage forms that should not be crushed: 1994 revision.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33990981" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Oral drug dosing following bariatric surgery: General concepts and specific dosing advice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18163192" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Need for multivitamin use in the postoperative period of gastric bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24464545" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Does patient compliance with follow-up influence weight loss after gastric bypass surgery? A systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16167356" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Caffeine ingestion and lower urinary tract symptoms in healthy volunteers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20152742" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Medical follow up after bariatric surgery: nutritional and drug issues. General recommendations for the prevention and treatment of nutritional deficiencies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24462340" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Patterns of physical activity and sedentary behavior after bariatric surgery: an observational study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28527156" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : The Effect of Aerobic or Aerobic-Strength Exercise on Body Composition and Functional Capacity in Patients with BMI≥35 after Bariatric Surgery: a Randomized Control Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23499190" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : The role of dietician follow-up in the success of bariatric surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31630324" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Relationship Between Bariatric Surgery and Gastroesophageal Reflux Disease: a Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28624531" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : The short- to mid-term symptom prevalence of dumping syndrome after primary gastric-bypass surgery and its impact on health-related quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27425831" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Prevalence, severity, and predictors of symptoms of dumping and hypoglycemia after Roux-en-Y gastric bypass.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32939660" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Which Factors Correlate with Marginal Ulcer After Surgery for Obesity?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36781593" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Perioperative Interventions to Prevent Gastroesophageal Reflux Disease and Marginal Ulcers After Bariatric Surgery - an International Experts' Survey.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30847736" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Changes in Bile Acid Metabolism, Transport, and Signaling as Central Drivers for Metabolic Improvements After Bariatric Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18574646" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26342481" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Randomized, Prospective Comparison of Ursodeoxycholic Acid for the Prevention of Gallstones after Sleeve Gastrectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37000381" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Incidence of Kidney Stones After Metabolic and Bariatric Surgery-Data from the Scandinavian Obesity Surgery Registry.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20610243" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Hyperoxaluria is a long-term consequence of Roux-en-Y Gastric bypass: a 2-year prospective longitudinal study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27396545" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Risk of nephrolithiasis, hyperoxaluria, and calcium oxalate supersaturation increased after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22407114" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : The effect of gastric bypass on the pharmacokinetics of serotonin reuptake inhibitors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23604695" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Gastric stenosis after laparoscopic sleeve gastrectomy in morbidly obese patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28726143" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Endoscopic management of post-laparoscopic sleeve gastrectomy stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26094664" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : The impact of bariatric surgery on quality of life: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27896646" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Improvement of Health-Related Quality of Life After Roux-en-Y Gastric Bypass Related to Weight Loss.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25820082" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Health-related quality of life after bariatric surgery: a systematic review of prospective long-term studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21944951" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Pre- to postoperative changes in physical activity: report from the longitudinal assessment of bariatric surgery-2 (LABS-2).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33331984" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Changes in Physical Activity in Relation to Body Composition, Fitness and Quality of Life after Primary Bariatric Surgery: a Two-Year Follow-Up Study.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
